3N Bio

About US

We are a life science-start-up that set out as a spin-off from Karolinska Institutet. We are committed to increase  efficiency, safety and speed in the development of small molecules modulating the microbiome. We have developed an new technology that provides  immediate information of the effect of new drug substances on the microbiome and facilitates the identification of phenotypic antimicrobial resistance.

TEAM

Susanne HUCH, PhD

Co-founder, CEO

LILIT NERSISYAN, PHD

Co-founder

VICENT PELECHANO, PHD

Co-founder, Chairman

Support

Location
Solna, Sweden
info@3n-bio.com